Amneal to Participate in Upcoming Investor Conferences
Amneal (Nasdaq: AMRX) announced executives will participate in two investor conferences and that presentations will be webcast.
Rhea-AI Summary
Amneal (Nasdaq: AMRX) announced executives will participate in two investor conferences and that presentations will be webcast. Chirag Patel, Co‑Chief Executive and President, and Tasos Konidaris, Chief Financial Officer, will join the Piper Sandler 2025 Healthcare Conference for a fireside chat on December 3, 2025 at 9:30 AM EST in New York. They will also present at the J.P. Morgan 2026 Healthcare Conference on January 13, 2026 at 4:30 PM PST in San Francisco. A webcast and limited-time replays will be available on Amneal's Investor Relations site.
Positive
- None.
Negative
- None.
Details
News Market Reaction – AMRX
On Dec 2, the day this news came out, AMRX closed 2.52% below the previous close.
Data tracked by StockTitan Argus for the Dec 2 session.
Key Figures
- Piper Sandler fireside chat
- December 3, 2025 at 9:30 AM EST
- Piper Sandler 2025 Healthcare Conference, New York
- Piper Sandler date
- December 3, 2025
- Piper Sandler 2025 Healthcare Conference
- J.P. Morgan conference dates
- January 12–15, 2026
- J.P. Morgan 2026 Healthcare Conference window
- J.P. Morgan presentation
- January 13, 2026 at 4:30 PM PST
- Company presentation at J.P. Morgan 2026 Healthcare Conference
Historical Context
-
U.S. FDA approval for epinephrine injection vials for hospital use.
-
Positive interim Phase 4 ELEVATE-PD results for CREXONT in Parkinson’s.
-
Announcement of participation in Piper Sandler and J.P. Morgan conferences.
-
FDA approval of albuterol sulfate inhalation aerosol, generic PROAIR HFA.
-
FDA approval of cyclosporine ophthalmic emulsion 0.05%, generic RESTASIS.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
webcast technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
BRIDGEWATER, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) today announced that Chirag Patel, Co-Chief Executive and President, and Tasos Konidaris, Chief Financial Officer, will participate in following upcoming investor conferences:
Piper Sandler 2025 Healthcare Conference
Date: December 3, 2025
Fireside Chat: Wednesday, December 3, 2025, at 9:30AM EST
Location: New York, NY
J.P. Morgan 2026 Healthcare Conference
Date: January 12-15, 2026
Presentation: Tuesday, January 13, 2026, at 4:30PM PST
Location: San Francisco, CA
A webcast of the presentations will be available on Amneal’s Investor Relations website at www.amneal.com/investors. Replays will be available for a limited time following each event.
About Amneal
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, NJ, is a global biopharmaceutical company. We make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of over 290 pharmaceuticals, primarily within the United States. In its Affordable Medicines segment, the Company is expanding across a broad range of complex product categories and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more information, please visit www.amneal.com and follow us on LinkedIn.
Investor Contact
Anthony DiMeo
VP, Investor Relations
anthony.dimeo@amneal.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.